Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

NCT06430684 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases
Pediatric Kidney Disease

Interventions

DRUG: Empagliflozin 10 MG

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Collaborators

[object Object]